Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.
Schmader KE, et al. Among authors: mcneil sa.
Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.
Clin Infect Dis. 2012.
PMID: 22291101
Free PMC article.
Clinical Trial.